Source:http://linkedlifedata.com/resource/pubmed/id/19291144
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2009-3-17
|
pubmed:abstractText |
This review addresses selected aspects of the management of severe healthcare-associated infections due to methicillin-resistant Staphylococcus aureus (MRSA), including the limitations of current therapy, potential alternative agents, new therapeutic options, clinical approaches to MRSA bacteraemia/endocarditis and ventilator-associated pneumonia, and strategies to improve outcomes in patients with severe MRSA infections.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1469-0691
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
125-36
|
pubmed:meshHeading | |
pubmed:year |
2009
|
pubmed:articleTitle |
Management of methicillin-resistant Staphylococcus aureus infections.
|
pubmed:affiliation |
Department of Medicine, Hospital Universitari Mutua de Terrassa, Terrassa, Barcelona, Spain. xgarau@mutuaterrassa.es
|
pubmed:publicationType |
Journal Article,
Review
|